Something went wrong.
There are no locations with the configured parameters:
Hours of Operation
Hours of Operation
Office Hours
Insurance accepted
Baylor Scott & White has established agreements with several types of insurances in an effort to make sure your health needs are covered.
-
Aetna - (23)STARGroup Retiree Medicare PPO - Limited to Exxon/MobilAetna Medicare Choice II Plan (PPO)Aetna Medicare Choice Plan (PPO)Aetna Medicare Eagle II (PPO)Health Network OptionSelectQPOSOpen Choice PPOAetna Medicare Freedom Preferred Plan (PPO)Aetna Medicare Prime Plan (HMO)Aetna Medicare Value Plan (HMO)Aetna Medicare Freedom Plan (PPO)Aetna Medicare Eagle Plan (PPO)HMOManaged ChoiceOpen Access Elect ChoiceOpen Access Managed ChoiceOpen Access SelectAetna Signature AdministratorsAetna Medicare Dual Complete Plan (HMO D-SNP)Health Network OnlyChoice POS II
-
American Health Advantage of Texas - (1)American Health Advantage of Texas HMO I-SNP
-
Baylor Scott & White Health Plan - (11)BSW Plus HMO-Individual/Family2023 BSW Employee Network (SEQA & EQA)BSW Extended PPOEPO Network-Individual/FamilyCovenant Health EPO NetworkBSW Access PPOBSW Preferred HMO - Individual MarketplaceCovenant Preferred HMO2023 BSW Employee Network (PPO & HSA)BSW SeniorCare Advantage PPOBSW Premier HMO-Group
-
Blue Cross Blue Shield - (26)ParPlanTRS-ActiveCare PrimaryTRS-ActiveCare Primary HDTRS-Care StandardBlue Advantage - BronzeBlue Advantage - GoldBlue Advantage - SilverTRS-ActiveCare 2Blue Advantage Plus - BronzeBlue Advantage Plus - GoldFederal Standard OptionBlue ChoiceTRS-ActiveCare Primary+Federal FEP Blue FocusBlue EssentialsBlue PremierBlue Premier AccessConsumer Directed HealthSelectFederal Basic OptionBlue Essentials AccessHealthSelectBlue Cross Medicare Advantage Dual Care Plus (HMO SNP)Blue Advantage Plus - SilverBlue Cross Group Medicare Advantage (PPO)Blue Cross Medicare Advantage (HMO)High Performance Network
-
Cigna - (9)Cigna Medicare AdvantageChoice FundCigna HealthSpringPoint of Service Open AccessOpen Access Plus In-NetworkOpen Access PlusOpen AccessLocalPlusLocalPlus In-Network
-
DFW ConnectedCare - (1)American Airlines Employee Benefit Plan
-
EHN - (1)Employers Health Network
-
First Health/Coventry - (1)First Health/Coventry Network
-
FirstCare Health Plans - (1)CHIP
-
HealthSmart - (2)Preferred NetworkAccel Network
-
Humana - (11)HumanaChoice (Regional PPO)HumanaChoice (PPO)Humana Gold Choice (PFFS)National POSPPOHumana Gold Plus (HMO)Humana PreferredHumana USAA Honor with Rx (PPO)Humana Honor (PPO)Humana Gold Plus SNP-DE (HMO D-SNP)ChoiceCare
-
Nebraska Furniture Mart - (3)PearlEmeraldOnyx
-
Superior Health Plan - (6)WellcareSTAR+PLUSAmbetter Core EPO - GoldWellcare by AllwellAmbetter Core EPO - SilverAmbetter Core EPO - Bronze
-
Superior HealthPlan - (1)STAR+PLUS
-
TriWest HealthCare - (1)Community Care Network
-
United HealthCare - (25)Choice PlusNavigateCharter PlusAll SaversNavigate BalancedNavigate PlusUnitedHealthcare Medicare Advantage Choice (Regional PPO)Nexus ACO - Open AccessChoiceAARP Medicare Advantage SecureHorizons Plan 1 (HMO-POS)AARP Medicare Advantage SecureHorizons Plan 2 (HMO-POS)AARP Medicare Advantage Walgreens (PPO)CoreCharterCore EssentialOptionsSurestUnitedHealthcare Group Medicare Advantage (PPO)SelectEDGESelect PlusAARP Medicare Advantage Choice (PPO)AARP Medicare Advantage Patriot (HMO-POS)Nexus ACO - Referral RequiredCharter Balanced
-
Imagine Health - (1)Imagine Health Network
-
Parkland Community Health Plan - (2)CHIPSTAR - HealthFirst
-
PHCS Network - (1)PHCS Primary PPO
We couldn’t find any results for ""
Medical conditions we treat
-
Acute liver failure
Acute liver failure
A condition in which the liver is unable to perform its normal metabolic functions. Liver failure is often triggered due to an overdose of acetaminophen, infections or because of prescription drugs. It happens in patients without long-term liver disease. The liver quits working within a very short time – within days or weeks. -
Alcohol-related liver disease
Alcohol-related liver disease
Inflammation of the liver caused by chronic heavy drinking of alcohol. Alcohol is the second most common cause of liver cirrhosis. -
Alpha-1-antitrypsin deficiency
Alpha-1-antitrypsin deficiency
A hereditary genetic disorder that may lead to the development of liver or lung disease. -
Amyloidosis
Amyloidosis
A disease in which abnormal proteins, known as amyloid fibrils, build up in tissue. There are several types with varying symptoms; including diarrhea, weight loss, fatigue, bleeding, numbness, swelling of the legs or enlargement of the spleen. -
Ascites
Ascites
Abnormal accumulation of fluid in the abdomen typically caused by chronic liver disease. Autoimmune hepatitis—a disease in which the body’s own immune system attacks the liver and causes it to become inflamed. The chronic disease if untreated, can lead to cirrhosis and liver failure. -
Cholangiocarcinoma
Cholangiocarcinoma
Also called bile duct cancer because it begins in the bile duct, which carries bile and digestive fluid through the liver. -
Cirrhosis
Cirrhosis
A degenerative disease of the liver resulting in scarring and liver failure most often caused by hepatitis, alcohol-related liver disease and non-alcoholic fatty liver disease. -
Fatty liver disease
Fatty liver disease
Excessive build-up of fat in the liver is referred to as fatty liver disease. -
Hemochromatosis
Hemochromatosis
An inherited condition in which the body absorbs and stores too much iron. The extra iron can build up in the liver and cause serious damage. Without treatment, the liver can fail. -
Hepatitis
Hepatitis
A viral infection that causes inflammation of the liver. -
Liver cancer
Liver cancer
The growth and spread of unhealthy cells in the liver. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is about twice as common in men than in women. -
Liver disease
Liver disease
Our hepatologists work with patients, families and colleagues in multiple fields to prevent, diagnose, treat and manage complications of liver disease. Treatment options depend on your liver disease diagnosis. Some liver diseases can be treated with medication or outpatient procedures, while others may require surgery or a liver transplant. -
Nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease
NAFLD is excessive fat buildup in the liver without another clear cause such as alcohol use. There are two types: non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). NASH also includes liver inflammation. -
Portal vein thrombosis
Portal vein thrombosis
A blockage or narrowing of the blood vessel that brings blood to the liver from the intestines. -
Primary biliary cholangitis (PBC)
Primary biliary cholangitis (PBC)
A chronic liver disease resulting from progressive destruction of the bile ducts in the liver. When the ducts are destroyed, bile builds up in the liver contributing to inflammation and scarring (fibrosis) which can eventually lead to cirrhosis. -
Primary sclerosing cholangitis (PSC)
Primary sclerosing cholangitis (PSC)
A slow progressing chronic disease that scars the bile ducts and can eventually block them. The bile builds up in the liver and makes it harder for the liver to work. The condition may lead to liver cancer. -
Toxic (drug-induced) liver injury
Toxic (drug-induced) liver injury
An uncommon but potentially fatal cause of liver disease associated with prescription medications, over-the-counter drugs, and herbal and dietary supplements. -
Varices
Varices
Abnormal, enlarged veins in the esophagus that commonly occurs when blood flow to the liver is blocked by a clot or scar tissue in the liver is known as varices. -
Wilson’s disease
Wilson’s disease
An inherited condition that causes the body to retain excess copper in the liver. If untreated, Wilson’s disease can cause liver failure and brain damage.
- Acute liver failure
- Alcohol-related liver disease
- Alpha-1-antitrypsin deficiency
- Amyloidosis
- Ascites
- Cholangiocarcinoma
- Cirrhosis
- Fatty liver disease
- Hemochromatosis
- Hepatitis
- Liver cancer
- Liver disease
- Nonalcoholic fatty liver disease
- Portal vein thrombosis
- Primary biliary cholangitis (PBC)
- Primary sclerosing cholangitis (PSC)
- Toxic (drug-induced) liver injury
- Varices
- Wilson’s disease
Acute liver failure
A condition in which the liver is unable to perform its normal metabolic functions. Liver failure is often triggered due to an overdose of acetaminophen, infections or because of prescription drugs. It happens in patients without long-term liver disease. The liver quits working within a very short time – within days or weeks.Alcohol-related liver disease
Inflammation of the liver caused by chronic heavy drinking of alcohol. Alcohol is the second most common cause of liver cirrhosis.Alpha-1-antitrypsin deficiency
A hereditary genetic disorder that may lead to the development of liver or lung disease.Amyloidosis
A disease in which abnormal proteins, known as amyloid fibrils, build up in tissue. There are several types with varying symptoms; including diarrhea, weight loss, fatigue, bleeding, numbness, swelling of the legs or enlargement of the spleen.Ascites
Abnormal accumulation of fluid in the abdomen typically caused by chronic liver disease. Autoimmune hepatitis—a disease in which the body’s own immune system attacks the liver and causes it to become inflamed. The chronic disease if untreated, can lead to cirrhosis and liver failure.Cholangiocarcinoma
Also called bile duct cancer because it begins in the bile duct, which carries bile and digestive fluid through the liver.Cirrhosis
A degenerative disease of the liver resulting in scarring and liver failure most often caused by hepatitis, alcohol-related liver disease and non-alcoholic fatty liver disease.Fatty liver disease
Excessive build-up of fat in the liver is referred to as fatty liver disease.Hemochromatosis
An inherited condition in which the body absorbs and stores too much iron. The extra iron can build up in the liver and cause serious damage. Without treatment, the liver can fail.Hepatitis
A viral infection that causes inflammation of the liver.Liver cancer
The growth and spread of unhealthy cells in the liver. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is about twice as common in men than in women.Liver disease
Our hepatologists work with patients, families and colleagues in multiple fields to prevent, diagnose, treat and manage complications of liver disease. Treatment options depend on your liver disease diagnosis. Some liver diseases can be treated with medication or outpatient procedures, while others may require surgery or a liver transplant.Nonalcoholic fatty liver disease
NAFLD is excessive fat buildup in the liver without another clear cause such as alcohol use. There are two types: non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). NASH also includes liver inflammation.Portal vein thrombosis
A blockage or narrowing of the blood vessel that brings blood to the liver from the intestines.Primary biliary cholangitis (PBC)
A chronic liver disease resulting from progressive destruction of the bile ducts in the liver. When the ducts are destroyed, bile builds up in the liver contributing to inflammation and scarring (fibrosis) which can eventually lead to cirrhosis.Primary sclerosing cholangitis (PSC)
A slow progressing chronic disease that scars the bile ducts and can eventually block them. The bile builds up in the liver and makes it harder for the liver to work. The condition may lead to liver cancer.Toxic (drug-induced) liver injury
An uncommon but potentially fatal cause of liver disease associated with prescription medications, over-the-counter drugs, and herbal and dietary supplements.Varices
Abnormal, enlarged veins in the esophagus that commonly occurs when blood flow to the liver is blocked by a clot or scar tissue in the liver is known as varices.Wilson’s disease
An inherited condition that causes the body to retain excess copper in the liver. If untreated, Wilson’s disease can cause liver failure and brain damage.Pay bill
Baylor Scott & White Health is pleased to offer you multiple options to pay your bill. View our guide to understand your Baylor Scott & White billing statement.
We offer two online payment options:
- Make a one-time payment without registering by selecting the "Pay a Bill as a Guest" option.
- Enroll or login to your MyBSWHealth account to view account balances and statements, setup a payment plan or enroll in paperless statements.
Other payment options:
-
Pay by mail
To ensure that your payment is correctly applied to your account, detach the slip from your Baylor Scott & White billing statement and return the slip with your payment. If paying by check or money order, include your account number on the check or money order.
Please mail the payment to the address listed on your statement.
-
Pay by phone
Payments to HTPN can be made over the phone with our automated phone payment system 24 hours a day, seven days a week. All payments made via the automated phone payment system will post the next business day. Please call 1.866.377.1650.
If you need to speak to someone about a bill from a Baylor Scott & White Hospital, our Customer Service department is available to take payments over the phone from Monday through Friday from 8:00 AM - 5:00 PM and can be reached at 1.800.994.0371.
-
Pay in person
Payments can be made in person at the facility where you received services.
Financial assistance
At Baylor Scott & White Health, we want to be a resource for you and your family. Our team of customer service representatives and financial counselors are here to help you find financial solutions that can help cover your cost of care. We encourage you to speak to a team member before, during or after care is received.
Patient forms
To ensure that your visit to our office is as convenient and efficient as possible, we are pleased to offer our registration forms online. The patient registration form may be completed electronically and printed for better legibility or completed manually.
Research and news
-
Therapy for NASH
Therapy for NASH
New medicine could melt away fat
A new therapy that could revolutionize how fatty liver disease is managed.
James Trotter, MD, Medical Director, Transplant Hepatology at Baylor University Medical Center is one of the chief investigators of a new therapy that could revolutionize how fatty liver disease is managed. According to the American Liver Foundation, 60 million Americans are living with nonalcoholic steatohepatitis (NASH) which is a part of a group of conditions that lead to fat buildup in the liver, inflammation and fibrosis. Early results were just published in The Lancet, one of the highest ranked medicine journals in the world.
Read article about new therapy for NASH -
Living donor study
Living donor study
Reducing barriers to living donor transplantation
This pilot study aims to determine how living donor transplant candidates fare after transplant. Data collection began in April 2018 and will continue over the next two years to provide people considering donating more detailed information about the long-term benefits and risks of living donation.Baylor University Medical Center is one of 16 sites nationwide participating in a pilot study to determine how living donor transplant candidates fare after transplant, whether they actually donate or not. There are six liver transplant sites, including Baylor, and ten kidney programs participating in the study. The need for solid organ transplants is still growing but living donor transplants have actually declined from their peak in 2004. One of the major barriers to living organ donation is that long-term outcomes for donors are unclear. The Scientific Registry of Transplant Recipients (SRTR) has now launched the Living Donor Collective (LDC) to establish a living donor registry to study the long-term outcomes of living organ donation.
More about the living donor collective
The goal of the project is to establish a living organ donor registry where all living donor candidates who are evaluated will be entered into a database. All aspects of their physical and psychosocial well-being will be tracked. The (LDC) will follow up approximately one year after the transplant surgery or a year after the decision not to donate. Donors and non-donors will be followed to monitor long-term outcomes of both groups. Ultimately, the research collected over the next two years will provide people considering donating more detailed information about the long-term benefits and risks of living donation. -
Hep C-positive organ donation
Hep C-positive organ donation
In the wake of the opioid crisis, more donated organs are infected with the hepatitis C virus, and many are declined as a result. But a Tarrant County woman says she's proof that.
Watch video: Infected organ saves the life of a Tarrant County woman -
Articles and videos
Articles and videos
- Global burden of alcohol-related liver disease is trending upward
- Mortality rate for chronic liver disease underestimated
- Sumeet Asrani, MD, discusses liver health
- Ask the Expert, Dr. Asrani discusses "What is liver disease"
- "Liver buddies" for life: Niece saves her aunt’s life through organ donation
- Liver transplant at Baylor Scott & White Health: Patient-centered care for the entire journey
- Hepatic encephalopathy with Dr. Trotter
- Happily ever after: Couple ties the knot after lifesaving liver transplant
Therapy for NASH
New medicine could melt away fat
A new therapy that could revolutionize how fatty liver disease is managed.
James Trotter, MD, Medical Director, Transplant Hepatology at Baylor University Medical Center is one of the chief investigators of a new therapy that could revolutionize how fatty liver disease is managed. According to the American Liver Foundation, 60 million Americans are living with nonalcoholic steatohepatitis (NASH) which is a part of a group of conditions that lead to fat buildup in the liver, inflammation and fibrosis. Early results were just published in The Lancet, one of the highest ranked medicine journals in the world.
Read article about new therapy for NASHLiving donor study
Reducing barriers to living donor transplantation
This pilot study aims to determine how living donor transplant candidates fare after transplant. Data collection began in April 2018 and will continue over the next two years to provide people considering donating more detailed information about the long-term benefits and risks of living donation.
Baylor University Medical Center is one of 16 sites nationwide participating in a pilot study to determine how living donor transplant candidates fare after transplant, whether they actually donate or not. There are six liver transplant sites, including Baylor, and ten kidney programs participating in the study. The need for solid organ transplants is still growing but living donor transplants have actually declined from their peak in 2004. One of the major barriers to living organ donation is that long-term outcomes for donors are unclear. The Scientific Registry of Transplant Recipients (SRTR) has now launched the Living Donor Collective (LDC) to establish a living donor registry to study the long-term outcomes of living organ donation.
The goal of the project is to establish a living organ donor registry where all living donor candidates who are evaluated will be entered into a database. All aspects of their physical and psychosocial well-being will be tracked. The (LDC) will follow up approximately one year after the transplant surgery or a year after the decision not to donate. Donors and non-donors will be followed to monitor long-term outcomes of both groups. Ultimately, the research collected over the next two years will provide people considering donating more detailed information about the long-term benefits and risks of living donation.
Hep C-positive organ donation
In the wake of the opioid crisis, more donated organs are infected with the hepatitis C virus, and many are declined as a result. But a Tarrant County woman says she's proof that.
Watch video: Infected organ saves the life of a Tarrant County womanArticles and videos
- Global burden of alcohol-related liver disease is trending upward
- Mortality rate for chronic liver disease underestimated
- Sumeet Asrani, MD, discusses liver health
- Ask the Expert, Dr. Asrani discusses "What is liver disease"
- "Liver buddies" for life: Niece saves her aunt’s life through organ donation
- Liver transplant at Baylor Scott & White Health: Patient-centered care for the entire journey
- Hepatic encephalopathy with Dr. Trotter
- Happily ever after: Couple ties the knot after lifesaving liver transplant